Cargando…
Inflammation in atherosclerosis: a cause or a result of vascular disorders?
Sound data support the concept that in atherosclerosis, inflammation and dyslipidemia intersect each other and that irrespective of the initiator, both participate from the early stages to the ultimate fate of the atheromatous plaque. The two partakers manoeuvre a vicious circle in atheroma formatio...
Autores principales: | Manduteanu, Ileana, Simionescu, Maya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822968/ https://www.ncbi.nlm.nih.gov/pubmed/22348535 http://dx.doi.org/10.1111/j.1582-4934.2012.01552.x |
Ejemplares similares
-
Aortic valve disease in diabetes: Molecular mechanisms and novel therapies
por: Manduteanu, Ileana, et al.
Publicado: (2021) -
P-Selectin Targeted Dexamethasone-Loaded Lipid Nanoemulsions: A Novel Therapy to Reduce Vascular Inflammation
por: Simion, Viorel, et al.
Publicado: (2016) -
Diabetes-induced early molecular and functional changes in aortic
heart valves in a murine model of atherosclerosis
por: Tucureanu, Monica Madalina, et al.
Publicado: (2019) -
‘Cellular dysfunction in inflammatory-related vascular disorders’ Review Series The inflammatory process: a new dimension of a 19(th) century old story
por: Simionescu, Maya
Publicado: (2009) -
Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis
por: Georgescu, Adriana, et al.
Publicado: (2021)